Med-X (MXRX) Long-Term Debt: $0.00 Mil (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Med-X Long-Term Debt?

Med-X MXRX Long-Term Debt is $0.00 Mil as of Dec. 2022.

Med-X's Long-Term Debt for the quarter that ended in Dec. 2022 was $0.00 Mil.

Med-X's quarterly Long-Term Debt declined from Dec. 2021 ($0.00 Mil) to Jun. 2022 ($0.00 Mil) but then stayed the same from Jun. 2022 ($0.00 Mil) to Dec. 2022 ($0.00 Mil).

Med-X's annual Long-Term Debt declined from Dec. 2020 ($0.01 Mil) to Dec. 2021 ($0.00 Mil) and declined from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil).

Med-X  (NAS:MXRX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Med-X Long-Term Debt Related Terms

Med-X Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Med-X's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Med-X Long-Term Debt Chart

Med-X Annual Data
Trend Dec20 Dec21 Dec22
Long-Term Debt
0.01 0.00 0.00

Med-X Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22
Long-Term Debt 0.01 0.00 0.00 0.00 0.00
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.00 Mil mean?
Med-X (MXRX) has a Long-Term Debt of $0.00 Mil as of Dec. 2022.
Is Med-X's Long-Term Debt too high?
Med-X's current Long-Term Debt is $0.00 Mil.
How does Med-X's Long-Term Debt compare to ?
Med-X's Long-Term Debt of $0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Consumer Packaged Goods company?
A good Long-Term Debt depends on the Consumer Packaged Goods industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Med-X's current Long-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med-X stock overvalued right now?
Med-X (MXRX) has a current Long-Term Debt of $0.00 Mil. The current Long-Term Debt is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Med-X (MXRX), the current Long-Term Debt is $0.00 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Med-X Business Description

Comparable Companies
Address 8236 Remmet Avenue, Canoga Park, CA, USA, 91304
Med-X Inc is engaged in the business of product development, distribution, and marketing of products, which currently consist of Nature-Cide, Thermal-Aid, and Malibu Brands. Nature-Cide products include natural essential oil blends of indoor and outdoor pesticide/insecticide/repellent developed for multiple industries, including professional pest control, turf care, janitorial, hospitality, transportation, and agriculture. Thermal-Aid, Thermal-Aid Zoo, and the Thermal-Aid Headache Relief System are natural heating/cooling pain and physical therapy products for painful ailments affecting adults, children, and animals. Nature-Cide. Malibu Brands has only one product available, an all-natural essential oil pain management cream.